Literature DB >> 11518808

A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action.

M C Zennaro1, A Souque, S Viengchareun, E Poisson, M Lombès.   

Abstract

Aldosterone effects are mediated by the MR, which possesses the same affinity for mineralocorticoids and glucocorticoids. In addition to the existence of mechanisms regulating intracellular hormone availability, we searched for human MR splice variants involved in tissue-specific corticosteroid function. We have identified a new human MR isoform, hMRDelta5,6, resulting from an alternative splicing event skipping exons 5 and 6 of the human MR gene. hMRDelta5,6 mRNAs are expressed in several human tissues at different levels compared with wild-type human MR, as shown by real time PCR. Introduction of a premature stop codon results in a 75-kDa protein lacking the entire hinge region and ligand binding domain. Interestingly, hMRDelta5,6 is still capable of binding to DNA and acts as a ligand-independent transactivator, with maximal transcriptional induction corresponding to approximately 30-40% of aldosterone-activated wild-type human MR. Coexpression of hMRDelta5,6 with human MR or human GR increases their transactivation potential at high doses of hormone. Finally, hMRDelta5,6 is able to recruit the coactivators, steroid receptor coactivator 1, receptor interacting protein 140, and transcription intermediary factor 1alpha, which enhance its transcriptional activity. Ligand-independent transactivation and enhancement of both wild-type MR and GR activities by hMRDelta5,6 suggests that this new variant might play a role in modulating corticosteroid effects in target tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518808     DOI: 10.1210/mend.15.9.0689

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  19 in total

Review 1.  Corticosteroid receptor genetic polymorphisms and stress responsivity.

Authors:  Roel DeRijk; E Ronald de Kloet
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

2.  Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.

Authors:  Li Ma; Lili Yuan; Jing An; Michelle C Barton; Qingyuan Zhang; Zhaoliang Liu
Journal:  Tumour Biol       Date:  2016-09-16

3.  Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.

Authors:  Jessica A Chadwick; J Spencer Hauck; Jeovanna Lowe; Jeremiah J Shaw; Denis C Guttridge; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  FASEB J       Date:  2015-07-15       Impact factor: 5.191

Review 4.  Central regulation of blood pressure by the mineralocorticoid receptor.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

5.  Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.

Authors:  Hirochika Kitagawa; Junn Yanagisawa; Hiroaki Fuse; Satoko Ogawa; Yoshiko Yogiashi; Atsuro Okuno; Hiromichi Nagasawa; Toshihiro Nakajima; Toshio Matsumoto; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1.

Authors:  Edwige-Ludiwyne Hubert; Raphaël Teissier; Fábio L Fernandes-Rosa; Michel Fay; Marie-Edith Rafestin-Oblin; Xavier Jeunemaitre; Chantal Metz; Brigitte Escoubet; Maria-Christina Zennaro
Journal:  J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 10.121

7.  Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display.

Authors:  Jun Yang; Ching-yi Chang; Rachid Safi; James Morgan; Donald P McDonnell; Peter J Fuller; Colin D Clyne; Morag J Young
Journal:  Mol Endocrinol       Date:  2010-11-24

Review 8.  The kidney and hypertension: pathogenesis of salt-sensitive hypertension.

Authors:  Tatsuo Shimosawa; Shengyu Mu; Shigeru Shibata; Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

9.  Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; Andrew V Schally; Gabor Halmos; Jozsef L Varga; Helen Koutselini; Anastasios Kalofoutis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

Review 10.  Sexual Dimorphism of Corticosteroid Signaling during Kidney Development.

Authors:  Margaux Laulhé; Laurence Dumeige; Thi An Vu; Imene Hani; Eric Pussard; Marc Lombès; Say Viengchareun; Laetitia Martinerie
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.